AI assistant
FIBROGEN INC — Director's Dealing 2024
Dec 18, 2024
34576_dirs_2024-12-18_61ec82c0-9b43-4978-888f-672d8651a510.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2024-12-16
Reporting Person: DeLucia David (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 118462 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.99 | 2032-06-02 | Common Stock (41100) | Direct | |
| Stock Option (Right to Buy) | $22.60 | 2033-02-20 | Common Stock (13600) | Direct | |
| Stock Option (Right to Buy) | $1.21 | 2033-08-29 | Common Stock (100000) | Direct | |
| Stock Option (Right to Buy) | $1.89 | 2034-02-21 | Common Stock (44000) | Direct |
Footnotes
F1: Twenty-five percent of the shares subject to the option vested on May 2, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F2: Twenty-five percent of the shares subject to the option vested on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F3: Twenty-five percent of the shares subject to the option vested on September 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F4: Twenty-five percent of the shares subject to the option will vest on March 1, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.